Etigilimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Etigilimab, covering 2025-03-17 to 2025-05-16. Get the full timeline:
Most recent: Clinical Trial Update: EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer [Phase 2]